Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Leukemia
|
October 3, 2002
How long can we give interleukin-2? Clinical and immunological evaluation of AML patients after 10 or more years of IL2 administration
G Meloni, S M Trisolini, S Capria, et al.
European Review for Medical and Pharmacological Sciences
|
June 22, 2021
Takotsubo cardiomyopathy and flecainide toxicity: a case report and brief literature review
A Moretti, M Polselli, I Carbone, et al.
Haematologica
|
May 1, 1990
High doses of ara-C and m-AMSA in the treatment of refractory acute non lymphocytic leukemia
R Latagliata, M C Petti, M A Spiriti, et al.
British Journal of Haematology
|
June 1, 1989
Interferon alpha-2b as treatment for Philadelphia-negative chronic myeloproliferative disorders with excessive thrombocytosis
M Lazzarino, A Vitale, E Morra, et al.
Haematologica
|
July 1, 1990
[Role of alpha-interferon in the therapy of essential thrombocythemia]
M Lazzarino, A Vitale, E Morra, et al.
European Journal of Haematology. Supplementum
|
January 1, 1990
Therapy of essential thrombocythemia with alpha-interferon: results and prospects
M Lazzarino, A Vitale, E Morra, et al.
European Review for Medical and Pharmacological Sciences
|
December 5, 2015
Is it possible a new definition of metabolic syndrome in childhood?
F Martino, G Pannarale, P E Puddu, et al.
American Journal of Nephrology
|
January 1, 1987
Risk of iron overload and 'hemochromatosis allele(s)' in patients on maintenance hemodialysis
M Taccone-Gallucci, G Di Nucci, C Meloni, et al.
Haematologica
|
October 17, 2001
High dose of idarubicin-based regimen for diffuse large cell AIDS-related non-Hodgkin's lymphoma patients: a pilot study
R Gastaldi, P Martino, G Gentile, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 13, 1998
The role of all-trans-retinoic acid (ATRA) treatment in newly-diagnosed acute promyelocytic leukemia patients aged > 60 years
R Latagliata, G Avvisati, F Lo Coco, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Leukemia
|
October 3, 2002
How long can we give interleukin-2? Clinical and immunological evaluation of AML patients after 10 or more years of IL2 administration
G Meloni, S M Trisolini, S Capria, et al.
European Review for Medical and Pharmacological Sciences
|
June 22, 2021
Takotsubo cardiomyopathy and flecainide toxicity: a case report and brief literature review
A Moretti, M Polselli, I Carbone, et al.
Haematologica
|
May 1, 1990
High doses of ara-C and m-AMSA in the treatment of refractory acute non lymphocytic leukemia
R Latagliata, M C Petti, M A Spiriti, et al.
British Journal of Haematology
|
June 1, 1989
Interferon alpha-2b as treatment for Philadelphia-negative chronic myeloproliferative disorders with excessive thrombocytosis
M Lazzarino, A Vitale, E Morra, et al.
Haematologica
|
July 1, 1990
[Role of alpha-interferon in the therapy of essential thrombocythemia]
M Lazzarino, A Vitale, E Morra, et al.
European Journal of Haematology. Supplementum
|
January 1, 1990
Therapy of essential thrombocythemia with alpha-interferon: results and prospects
M Lazzarino, A Vitale, E Morra, et al.
European Review for Medical and Pharmacological Sciences
|
December 5, 2015
Is it possible a new definition of metabolic syndrome in childhood?
F Martino, G Pannarale, P E Puddu, et al.
American Journal of Nephrology
|
January 1, 1987
Risk of iron overload and 'hemochromatosis allele(s)' in patients on maintenance hemodialysis
M Taccone-Gallucci, G Di Nucci, C Meloni, et al.
Haematologica
|
October 17, 2001
High dose of idarubicin-based regimen for diffuse large cell AIDS-related non-Hodgkin's lymphoma patients: a pilot study
R Gastaldi, P Martino, G Gentile, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 13, 1998
The role of all-trans-retinoic acid (ATRA) treatment in newly-diagnosed acute promyelocytic leukemia patients aged > 60 years
R Latagliata, G Avvisati, F Lo Coco, et al.
Page
of 2